Hiperplasia gingival por ciclosporina: A propĆ³sito de un caso

dc.contributor.authorBahamondes B., Carlos
dc.contributor.authorGodoy O., Jorge
dc.date.accessioned2013-12-19T21:13:56Z
dc.date.accessioned2016-05-31T20:13:08Z
dc.date.available2013-12-19T21:13:56Z
dc.date.available2016-05-31T20:13:08Z
dc.date.issued2007
dc.descriptionIndexaciĆ³n: Scielo
dc.description.abstractGingival enlargement can be an adverse effect of ciclosporine A and nifedipine use. It has a high relapse rate if the drugs are not discontinued. There is a genetic predisposition to the development of this condition and dental biofilm can also play a role. We report a 64 years old male who received a renal allograft and was treated with cyclosporine and nifedipine. He required six surgical interventions for generalized gingival enlargement. After the sixth relapse, the patient was subjected to a periodontal treatment to eliminate the dental biofilm, which decreased the rate of recurrence of gingival enlargement.en
dc.description.urihttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000300013&nrm=iso
dc.identifier.citationRevista mĆ©dica de Chile, Vol. 135, NĀ° 3, pp. 370-374, 2007.es
dc.identifier.issn0034-9887
dc.identifier.urihttp://repositorio.unab.cl/xmlui/handle/ria/2271
dc.language.isoeses
dc.publisherSociedad MĆ©dica de Santiagoes
dc.subjectBiofilmes
dc.subjectCyclosporinees
dc.subjectGingival hyperplasiaes
dc.subjectHiperplasia gingivales
dc.subjectCiclosporinaes
dc.titleHiperplasia gingival por ciclosporina: A propĆ³sito de un casoes
dc.typeArtĆ­culoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Bahamondes_Hiperplasia gingival por ciclosporina A propĆ³sito de un caso_2007.pdf
TamaƱo:
72.99 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 2 de 2
No hay miniatura disponible
Nombre:
license.txt
TamaƱo:
1.71 KB
Formato:
Item-specific license agreed upon to submission
DescripciĆ³n:
No hay miniatura disponible
Nombre:
license.txt
TamaƱo:
1.71 KB
Formato:
Item-specific license agreed upon to submission
DescripciĆ³n: